Evidence map›Paper›PMID 25883386›Full record

ArticleThe Journal of infectious diseases2015

Elevated Expression of CD160 and 2B4 Defines a Cytolytic HIV-Specific CD8+ T-Cell Population in Elite Controllers.

Carolina Pombo, E John Wherry, Emma Gostick, David A Price, Michael R Betts

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. IL-27 effects on HIVFrontiers in virology (Lausanne, Switzerland) · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. T-cell exhaustion in HIV infection.Immunological reviews · 2019
    Review
  16. CD160 Stimulates CD8ImmunoHorizons · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Carolina PomboDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
E John WherryDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Emma GostickInstitute of Infection and Immunity, Cardiff University School of Medicine, United Kingdom.
David A PriceHuman Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland Institute of Infection and Immunity, Cardiff University School of Medicine, United Kingdom.
Michael R BettsDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
University of Pennsylvania · USInstitute of Infection and Immunity · CA

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ROBERT GROSS · 1999 to 2026
$78.6M
TRAINING IN HIV PATHOGENESIST32AI007632 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Frederic D Bushman, James L. Riley · 2000 to 2026
$10.6M
T cell functionality and control of HIV infectionR01AI076066 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BETTS, MICHAEL R · 2008 to 2017
$4.6M
NIAID NIH HHS P30 AI045008NIAID NIH HHS R01 AI076066NIAID NIH HHS T32 AI007632NIAID NIH HHS T32 AI 07632PHS HHS R01 A1076066Wellcome Trust 100326
6 · The paper itself

Abstract

During chronic human immunodeficiency virus (HIV) infection, virus-specific CD8(+) T cells become functionally exhausted. Unlike most chronically infected individuals, elite controllers of HIV retain CD8(+) T-cell polyfunctionality and cytolytic capacity. It remains unclear whether elite controllers manifest T-cell exhaustion similar to subjects with chronic progression of HIV infection. Here we assessed coexpression of PD-1, Lag-3, CD160, and 2B4 as a measure of T-cell exhaustion in a cohort of elite controllers and in chronic progressors. We found that elite controllers have a high proportion of potentially exhausted (PD1(+)CD160(+)2B4(+)) HIV-specific CD8(+) T cells that is comparable to the proportion in chronic progressors. However, elite controllers also harbor a population of HIV-specific CD160(+)2B4(+) CD8(+) T cells that correlates with cytolytic capacity, as measured by perforin expression, a population not commonly present in chronic progressors. We therefore propose that coexpression of CD160 and 2B4 delineates a population of cytolytic CD8(+) T cells important for the control of HIV.

Indexed as

Antigens, CDCD8-Positive T-LymphocytesChronic DiseaseGenetic MarkersGPI-Linked ProteinsHIV-1HIV InfectionsHumansLeukocytes, MononuclearLymphocyte Activation Gene 3 ProteinPerforinProgrammed Cell Death 1 ReceptorReceptors, ImmunologicRNA, ViralSignaling Lymphocytic Activation Molecule FamilyAntigens, CDCD160 protein, humanCD244 protein, humanGenetic MarkersGPI-Linked ProteinsLymphocyte Activation Gene 3 ProteinPDCD1 protein, humanPerforinProgrammed Cell Death 1 ReceptorReceptors, ImmunologicRNA, ViralSignaling Lymphocytic Activation Molecule Family2B4CD160CD8+ T cellselite controllersHIVPD-1T-cell exhaustion

Identifiers

PMID25883386
PMCPMC4601914
OpenAlexW2052728085

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.